Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/27/2007 | US20070298464 Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same |
12/27/2007 | US20070298463 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
12/27/2007 | US20070298460 Novel receptor that causes cell death |
12/27/2007 | US20070298459 Death Domain Containing Receptor 6; severe combined immunodeficiency (SCID); adenosine deaminase deficiency, agammaglobulinemia Bruton's disease |
12/27/2007 | US20070298457 Soluble endoproteases for the in vitro processing of recombinant proteins |
12/27/2007 | US20070298455 Method For Preparing A Modified Host Cell |
12/27/2007 | US20070298449 Utilization of Cell Forcibly Expressing Toll-Like Receptor |
12/27/2007 | US20070298445 Cancer Therapeutic |
12/27/2007 | US20070298443 Screening Method Using Antibody Heavy Chains |
12/27/2007 | US20070298437 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a chloride intracellular channel 1 protein |
12/27/2007 | US20070298434 Library of Toxin Mutants, and Methods of Using Same |
12/27/2007 | US20070298430 Ribosome Display or Mrna Display Method With Selection for Increased Stability of the Protein |
12/27/2007 | US20070298418 Molecules Involved in Protein Folding |
12/27/2007 | US20070298417 Constructs for gene expression analysis |
12/27/2007 | US20070298415 Method of Amplifying Nucleic Acid |
12/27/2007 | US20070298414 Engineering Enzymes Through Genetic Selection |
12/27/2007 | US20070298145 Enzymes |
12/27/2007 | US20070298118 Exosome transfer of nucleic acids to cells |
12/27/2007 | US20070298056 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells |
12/27/2007 | US20070298054 genetically stable vaccinia viruses and vaccinia virus vectors with higher safety, which undergo reversion with difficulty because of the removal of a gene involved in reversion from an attenuated smallpox vaccinia virus LC16m8 strain or its parental LC16mO strain, which tends to undergo reverse mutation |
12/27/2007 | US20070298048 Non-viral gene delivery system |
12/27/2007 | US20070298043 Novel Antibacterial Agents and Methods of Identifying and Utilizing Same |
12/27/2007 | US20070298041 Ligands That Enhance Endogenous Compounds |
12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
12/27/2007 | US20070298037 administering antagonist to ztnfr14 comprising antibodies, antibody fragments, proteins or polypeptides, for the treatment of psoriasis, inflammatory bowel disease or multiple sclerosis in mammals |
12/27/2007 | US20070298036 PRO71238 Polypeptides |
12/27/2007 | US20070298035 Recombinant immunoglobulin for targeting, treatment and prevention of cancer, transplant rejection and viral infection |
12/27/2007 | US20070298026 Methods for Identifying Treatment and Inducing Infertility Using Smc1-Beta |
12/27/2007 | US20070298021 Methods and Compositions for the Treatment or Prevention of Secondary Ischemic Injury |
12/27/2007 | US20070298014 Probiotic therapy of neonatal meningitis and method of using E. coli virulence determinants |
12/27/2007 | US20070298006 Dendritic Polymers With Enhanced Amplification and Interior Functionality |
12/27/2007 | US20070297984 Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses |
12/27/2007 | US20070295252 Gene regulatory element polynucleotide molecules isolated from the Zea mays genes fructose 1-6 bisphosphate aldolase (FDA), pyruvate orthophosphate dikinase (PPDK), or ribulose bisphosphate carboxylase activase (RUA) |
12/27/2007 | DE102006029620A1 Polynucleotides useful for producing plants with increased cold and salt stress resistance are derived from the marine diatom Fragilariopsis cylindrus |
12/27/2007 | DE102006029129A1 Pathogen induzierbarer synthetischer Promotor Pathogen inducible synthetic promoter |
12/27/2007 | CA2826738A1 Polynucleotides and polypeptide sequences involved in cancer |
12/27/2007 | CA2805052A1 Pathogen-inducible synthetic promoter |
12/27/2007 | CA2691767A1 Dna molecules and methods |
12/27/2007 | CA2658926A1 Cosmid vector for transforming plant and use thereof |
12/27/2007 | CA2657998A1 Preparation of dough and baked products |
12/27/2007 | CA2657217A1 Dna composition against tumor stromal antigen fap and methods of use thereof |
12/27/2007 | CA2656707A1 Nucleic acid molecules encoding an enzyme that degrades long chain n-alkanes |
12/27/2007 | CA2656259A1 Process for producing poxviruses and poxvirus compositions |
12/27/2007 | CA2656258A1 Use of plant chromatin remodeling genes for modulating plant architecture and growth |
12/27/2007 | CA2656022A1 Single-molecule pcr on microparticles in water-in-oil emulsions |
12/27/2007 | CA2655957A1 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells |
12/27/2007 | CA2655933A1 Polynucleotides and polypeptide sequences involved in cancer |
12/27/2007 | CA2655882A1 Tfla gene which can degrade toxoflavin and its chemical derivatives and transgenic organisms expressing tfla gene |
12/27/2007 | CA2655544A1 Fatty acid hydroxylases and uses thereof |
12/27/2007 | CA2655497A1 Dpyd gene variants and use thereof |
12/27/2007 | CA2655121A1 Dna fragmentation assay |
12/27/2007 | CA2652461A1 Antifungal polypeptides and uses therof in inducing fungal resistance in plants |
12/26/2007 | EP1870709A1 Probe array and process for producing the same |
12/26/2007 | EP1870473A1 Adeno-associated virus-mediated delivery of angiogenic factors |
12/26/2007 | EP1870472A1 Model animal of Alzheimer's disease and use thereof |
12/26/2007 | EP1870471A1 Method for generation of mutants in Plants |
12/26/2007 | EP1870470A2 Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant |
12/26/2007 | EP1870469A1 Novel altered gene from rice anthranilic acid synthase gene oasa2 and use thereof |
12/26/2007 | EP1870468A2 LPS with reduced toxicity from genetically modified gram negative bacteria |
12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
12/26/2007 | EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer |
12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
12/26/2007 | EP1870464A2 Methods and compositions for inhibiting neoplastic cell growth |
12/26/2007 | EP1870463A1 High-affinity rna aptamer molecule for glutathione s-transferase protein |
12/26/2007 | EP1870462A1 Method for extracting nucleic acid |
12/26/2007 | EP1870461A2 Method for identifying within a mammal a DNA encoding physiologically active polypeptide |
12/26/2007 | EP1870460A1 Methods of producing proteins having triple-helix structure |
12/26/2007 | EP1870459A1 Methods for producing polypeptides by regulating polypeptide association |
12/26/2007 | EP1870458A1 sc(Fv)2 STRUCTURAL ISOMERS |
12/26/2007 | EP1870457A1 Dipeptide crystals and process for production thereof |
12/26/2007 | EP1870456A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method |
12/26/2007 | EP1870454A1 Method for producing dipeptide |
12/26/2007 | EP1870453A1 Novel protease, microorganism producing the same, and application thereof |
12/26/2007 | EP1870422A1 Means for the treatment of diseases characterized by an excessive immune reaction |
12/26/2007 | EP1870421A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate |
12/26/2007 | EP1870417A2 Peptide acceptor ligation methods |
12/26/2007 | EP1869961A2 Automated seed sampler and methods of sampling, testing and bulking seeds |
12/26/2007 | EP1869464A2 Rage/diaphanous interaction and related compositions and methods |
12/26/2007 | EP1869210A2 Peptide stabilizer compounds and screening method |
12/26/2007 | EP1869193A1 Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates |
12/26/2007 | EP1869192A2 Framework-shuffling of antibodies |
12/26/2007 | EP1869191A1 Novel neural cell specific promoter and baculovirus and method for gene delivery |
12/26/2007 | EP1869190A1 Gene delivery system containing decorin gene and pharmaceutical composition for treating cancer containing the system |
12/26/2007 | EP1869189A2 Alteration of plant embryo/endosperm size during seed development |
12/26/2007 | EP1869188A1 Cis-acting regulatory elements from tripsacum dactyloides |
12/26/2007 | EP1869187A2 Elite event a2704-12 and methods and kits for identifying such event in biological samples |
12/26/2007 | EP1869186A2 Methods and means for removal of a selected dna sequence |
12/26/2007 | EP1869185A1 Conjugate comprising p21 protein for the treatment of cancer |
12/26/2007 | EP1869184A1 Identification of a beta-1,3-n-acetylgalactosaminyltransferase (cgte) from campylobacter jejuni lio87 |
12/26/2007 | EP1869183A2 Theileria parva dna vaccines |
12/26/2007 | EP1869182A1 Method for isolation of soluble polypeptides |
12/26/2007 | EP1869181A2 Influenza therapeutic |
12/26/2007 | EP1869179A2 Method for treating a sample that contains biomolecules |
12/26/2007 | EP1869178A1 Promoter for the expression of foreign genes in neuronal cells |
12/26/2007 | EP1869177A2 A method for achieving high-level expression of recombinant human interleukin-2 upon destabilization of the rna secondary structure |
12/26/2007 | EP1869176A1 Apparatus for recovering specific substance and nucleic acid extracting apparatus using the same |
12/26/2007 | EP1869173A2 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
12/26/2007 | EP1869160A2 Gene inactivated mutants with altered protein production |
12/26/2007 | EP1869089A1 Phosphorylated waxy potato starch |
12/26/2007 | EP1869085A2 Novel anti-plgf antibody |